Evidence map›Paper›PMID 29097916›Full record

ArticleContrast media & molecular imaging2017

A Method for Manufacturing Oncological Phantoms for the Quantification of 18F-FDG PET and DW-MRI Studies.

Francesca Gallivanone, Irene Carne, Matteo Interlenghi, Daniela D'Ambrosio, Maurizia Baldi, Daniele Fantinato, Isabella Castiglioni

Abstract read
In one paragraph

Article in Contrast media & molecular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Francesca GallivanoneInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Milan, Italy.ORCID 0000-0001-6559-6157
Irene CarneMedical Physics Unit, IRCCS Fondazione S. Maugeri, Pavia, Italy.
Matteo InterlenghiInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Milan, Italy.
Daniela D'AmbrosioMedical Physics Unit, IRCCS Fondazione S. Maugeri, Pavia, Italy.ORCID 0000-0003-1485-6259
Maurizia BaldiDepartment of Diagnostic Imaging, IRCCS Fondazione S. Maugeri, Pavia, Italy.
Daniele FantinatoMedical Physics Unit, IRCCS Fondazione S. Maugeri, Pavia, Italy.
Isabella CastiglioniInstitute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Milan, Italy.ORCID 0000-0001-7191-5417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this work was to develop a method to manufacture oncological phantoms for quantitation purposes in 18F-FDG PET and DW-MRI studies. Radioactive and diffusion materials were prepared using a mixture of agarose and sucrose radioactive gels. T2 relaxation and diffusion properties of gels at different sucrose concentrations were evaluated. Realistic oncological lesions were created using 3D-printed plastic molds filled with the gel mixture. Once solidified, gels were extracted from molds and immersed in a low-radioactivity gel simulating normal background tissue. A breast cancer phantom was manufactured using the proposed method as an exploratory feasibility study, including several realistic oncological configurations in terms of both radioactivity and diffusion. The phantom was acquired in PET with 18F-FDG, immediately after solidification, and in DW-MRI the following day. Functional volumes characterizing the simulated BC lesions were segmented from PET and DW-MRI images. Measured radioactive uptake and ADC values were compared with gold standards. Phantom preparation was straightforward, and the time schedule was compatible with both PET and MRI measurements. Lesions appeared on 18F-FDG PET and DW-MRI images as expected, without visible artifacts. Lesion functional parameters revealed the phantom's potential for validating quantification methods, in particular for new generation hybrid PET-MRI systems.

Indexed as

Phantoms, ImagingBreast NeoplasmsDiffusion Magnetic Resonance ImagingFemaleFluorodeoxyglucose F18HumansMethodsPositron-Emission TomographyRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID29097916
PMCPMC5612673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.